Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 267 of 1,261

  1. US 11325925

    Dihydropyridazine antioxidant sunscreens

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 10, 2022 · Expires May 5, 2042

    granted

  2. US 11324935

    Implants for localized drug delivery and methods of use thereof

    The Regents of the University of California · Granted May 10, 2022 · Expires May 5, 2042

    granted

  3. US 11325902

    Benzenesulfonamide compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted May 10, 2022 · Expires May 5, 2042

    granted

  4. US 11326156

    Modified caspase-9 polypeptides and methods of use thereof

    Allogene Therapeutics, Inc. · Granted May 10, 2022 · Expires May 5, 2042

    granted

  5. US 11324813

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted May 10, 2022 · Expires May 5, 2042

    granted

  6. US 11324760

    Solid dispersion of dutasteride, method for preparing the solid dispersion, and pharmaceutical composition including the solid dispersion

    KOREA PRIME PHARM CO., LTD. · Granted May 10, 2022 · Expires May 5, 2042

    granted

  7. US 11318196

    Attenuated mutant dengue viruses comprising a mutation in the NS5 non-structural protein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  8. US 11318133

    Modulators of integrated stress response pathway

    PRAXIS BIOTECH LLC · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  9. US 11318100

    Storage stable sincalide formulations

    MAIA PHARMACEUTICALS, INC. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  10. US 11319536

    Modulating apolipoprotein (a) expression

    Ionis Pharmaceuticals, Inc. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  11. US 11319375

    Methods and compositions for treating subjects having rheumatoid arthritis

    REGENERON PHARMACEUTICALS, INC. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  12. US 11317968

    Methods and compositions for tissue adhesives

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  13. US 11318224

    Nanofiber structures and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  14. US 11319356

    Interferon alpha 2B variants

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  15. US 11319539

    Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  16. US 11319330

    Tricyclic furan-substituted piperidinedione compound

    Medshine Discovery Inc. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  17. US 11318098

    Liposomal apparatus and manufacturing methods

    ARBUTUS BIOPHARMA CORPORATION · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  18. US 11317888

    Non-invasive method for pressure measurement

    GE Precision Healthcare LLC · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  19. US 11318190

    Methods and compositions for treating liver disease

    United States Government as represented by the Department of Veterans Affairs · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  20. US 11319286

    Heterocyclic compound and application thereof

    Takeda Pharmaceutical Company Limited · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  21. US 11319290

    Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same

    Mebias Discovery, Inc. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  22. US 11318186

    Use of FGF21 in methods of increasing exocrine pancreatic secretion

    The Board of Regents of the University of Texas System · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  23. US 11319298

    Heteroaryl piperidine ether allosteric modulators of the M4 muscarinic acetylcholine receptor

    MSD R&D (China) Co. Ltd. · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

  24. US 11318211

    Dosage regimes for the administration of an anti-CD19 ADC

    ADC THERAPEUTICS SA · Granted May 3, 2022 · Expires Apr 28, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.